Loop Diuretics in Clinical Practice.
- Author:
Se Won OH
1
;
Sang Youb HAN
Author Information
- Publication Type:Review
- Keywords: Loop diuretics; Furosemide; Chronic kidney disease
- MeSH: Biological Availability; Diuretics; Edema; Furosemide; Humans; Renal Insufficiency, Chronic; Sodium; Sodium Potassium Chloride Symporter Inhibitors*
- From:Electrolytes & Blood Pressure 2015;13(1):17-21
- CountryRepublic of Korea
- Language:English
- Abstract: Diuretics are commonly used to control edema across various clinical fields. Diuretics inhibit sodium reabsorption in specific renal tubules, resulting in increased urinary sodium and water excretion. Loop diuretics are the most potent diuretics. In this article, we review five important aspects of loop diuretics, in particular furosemide, which must be considered when prescribing this medicine: (1) oral versus intravenous treatment, (2) dosage, (3) continuous versus bolus infusion, (4) application in chronic kidney disease patients, and (5) side effects. The bioavailability of furosemide differs between oral and intravenous therapy. Additionally, the threshold and ceiling doses of furosemide differ according to the particular clinical condition of the patient, for example in patients with severe edema or chronic kidney disease. To maximize the efficiency of furosemide, a clear understanding of how the mode of delivery will impact bioavailability and the required dosage is necessary.
